Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage

This study has been completed.
Consejeria de Salud. Junta de Andalucia. Spain
Information provided by:
Sociedad Andaluza de Enfermedades Infecciosas Identifier:
First received: November 8, 2007
Last updated: January 14, 2009
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):